Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Halozyme Therapeutic (NQ: HALO )

48.30 +1.70 (+3.65%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 27, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 983,474
Open 46.77
Bid (Size) 45.00 (5)
Ask (Size) 49.90 (2)
Prev. Close 46.60
Today's Range 46.37 - 48.34
52wk Range 31.36 - 48.34
Shares Outstanding 142,334,900
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Cannabis Movers & Shakers: Mind Medicine, 22nd Century Group, Grown Rogue International
Mind Medicine Names New CEO Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) has hired Schond L. Greenway to oversee its finance department. 
Via Benzinga
MindMed Appoints Schond L. Greenway As CFO
Mind Medicine Inc. (NASDAQ: MNMD), (NEO:MMED), a clinical stage bio-pharmaceutical company developing novel products to treat brain health disorders, appointed Schond L. Greenway as CFO. 
Via Benzinga

Performance

YTD
+17.63%
+17.63%
1 Month
+15.03%
+15.03%
3 Month
+35.94%
+35.94%
6 Month
+42.69%
+42.69%
1 Year
+15.69%
+15.69%

More News

Read More
Recap: Halozyme Therapeutics Q1 Earnings
Via Benzinga
Halozyme Therapeutics's Earnings Outlook
Via Benzinga
Why Is Sierra Oncology (SRRA) Stock Up Today?
Via InvestorPlace
Halozyme, Chugai Ink $185M ENHANZE Technology Licensing Pact
Via Benzinga
Earnings Scheduled For February 22, 2022
Via Benzinga
Why Antares Pharma Stock Is Soaring Today
Via Benzinga
Why Is Antares Pharma (ATRS) Stock Up Today?
Via InvestorPlace
Benzinga's Daily Brief On Trending Tickers For April 13, 2022: JPMorgan, PayPal, Bed Bath & Beyond And More
Via Benzinga
Biotech Stock Sierra Soars On GSK Buyout As Halozyme Nabs Antares
Via Investor's Business Daily
The Daily Biotech Pulse: GlaxoSmithKline And Halozyme Go Shopping, Mylan's Insulin Glargine Recall, Turning Point Shares Lung Cancer Data And More
Via Benzinga
Morning Brief: Top Stories Dominating Financial Media on Wednesday, April 13
Via Benzinga
Halozyme Buys Antares In $960M Deal To Create One Drug Delivery, Specialty Product Entity
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Janssen Partner Genmab Loses Arbitration Over Darzalex Royalties
Via Benzinga
Argenx's Subcutaneous Efgartigimod At Par With Intravenous Administration In Neuromuscular Disorder
Via Benzinga
Halozyme's Q4 Earnings Beat Consensus Despite Lower Product Sales Hit Topline Growth
Via Benzinga
Halozyme Therapeutics: Q4 Earnings Insights
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
Via Benzinga
The Daily Biotech Pulse: Lilly Sings Metabolic Disorder Drug Pact, Moderna Reports Positive Flu Vaccine Data, Halozyme To Buy Back Shares
Via Benzinga
7 Best Drug Stocks to Buy for 2022 Without Covid Catalysts
Via InvestorPlace
Exposures COVID-19
Janssen's Subcutaneous Darzalex Combo Wins FDA Approval For Pretreated Multiple Myeloma
Via Benzinga
Exposures Product Safety
Halozyme's Q3 Sales Boosted By Darzalex; Lifts FY21 Earnings Outlook
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.